Jeff Goater

Jeff Goater is a seasoned professional with extensive experience in the biotech sector. Currently serving as a board member for Topo Therapeutics, NILO Therapeutics, Kenai Therapeutics, Remix Therapeutics, Kallyope, and Ribon Therapeutics, Jeff also holds positions as Partner and Venture Partner at The Column Group, Chair at AviadoBio, and Executive Chair at Judo Bio. Prior roles include Interim CEO at Atavistik Bio and contributions at Ribon Therapeutics. Jeff's academic background includes an MS in Pathology/Molecular Medicine and an MS in Microbiology/Immunology from the University of Rochester School of Medicine and Dentistry, an MBA from the University of Rochester - Simon Business School, and a BA in Biology from the University of Rochester.